Cingulate to Host CNS Key Opinion Leader Panel in New York
Expert Analysis of Cingulate, its Phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform Innovations...
Source: globenewswire.com
Nasdaq Cingw News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Cingw. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Cingw Today - Breaking & Trending Today
Cingulate Inc. Reports First Quarter 2023 Financial Results
Additional $3 Million of Financing Proprietary PTR™ Manufacturing Processes Successfully Transferred to Societal CDMO Joint Commercialization Agreement for...
Source: globenewswire.com
Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301,
Trial Results Expected 1H 2023 Company to Host Investor and Business Development Meetings Adjacent to Upcoming J.P. Morgan Healthcare Conference in...
Source: globenewswire.com
Cingulate and ADHD Expert Dr. Ann Childress, MD to
KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary...
Source: globenewswire.com
Cingulate Inc. Announces Pricing of $25.0 Million Initial
KANSAS CITY, Kan., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing...
Source: globenewswire.com